Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,121 public trials 2,033 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Disease Registry of Patients With Mantle Cell Lymphoma

NCT03816683

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Research Site Montgomery, Alabama, United States
  • Research Site Clovis, California, United States
  • Research Site Boulder, Colorado, United States
  • Research Site Jacksonville, Florida, United States
View all 32 locations
View Trial Details
Completed

Gender/Sex & CUD Remission

NCT04964739

Conditions
Cannabis Use Disorder, Mild, Cannabis Use Disorder, Moderate, Cannabis Use Disorder, Severe, +10 more
Locations
  • Medical University of South Carolina Charleston, South Carolina, United States
View Trial Details
Completed

Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts

NCT03160079

Conditions
B-Cell Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations
  • UCSF Fresno Community Cancer Institute Clovis, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UC Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
View Trial Details
Completed

Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia

NCT02242942

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • UC San Diego Health System La Jolla, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 122 locations
View Trial Details
Completed

A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study

NCT02875548

Conditions
Adenoma, Advanced Solid Tumors, Diffuse Large B-Cell Lymphoma (DLBCL), +24 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • California Cancer Associates For Research And Excellence, cCARE Santa Fe, California, United States
  • Hematology Oncology Associates of the Treasure Coast - Port St. Lucie Port Saint Lucie, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 34 locations
View Trial Details
Completed

Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT02199665

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Mayo Clinic (AZ) Scottsdale, Arizona, United States
  • University of Chicago Chicago, Illinois, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Wayne State University Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details

Related conditions